Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $97.6, a high estimate of $103.00, and a low estimate of $93.00. This upward trend ...
In the preceding three months, 5 analysts have released ratings for Globus Medical (NYSE:GMED), presenting a wide array of perspectives from bullish to bearish. The table below summarizes their ...
Globus Medical GMED recently launched the COHERE ALIF Spacer, the first Porous PEEK interbody spacer for anterior lumbar interbody fusion (ALIF) surgery. Additionally, the company introduced ...
Globus Medical, Inc. (NYSE:GMED – Free Report) – Research analysts at Roth Capital lowered their Q1 2025 earnings estimates for Globus Medical in a research report issued to clients and ...
Piper Sandler analyst Matthew O’Brien maintained a Buy rating on Globus Medical (GMED – Research Report) today and set a price target of $100.00. The company’s shares closed last Friday at ...
A prior version of the Medical Supply Chain Resiliency Act had previously been introduced in both chambers in 2023, again with bipartisan support. The latest version comes as trade deals with ...
Tariffs are back in the headlines, and "The Ramsey Show" co-host Ken Coleman isn't having it. In a recent episode, a caller's financial dilemma turned into a fiery discussion on trade wars ...